Field notes on things that run themselves
The Bandage That Digests Itself
A scab looks like the most static thing on your body — a hard little lid clamped over a scrape until the skin underneath grows back. It is very nearly the opposite: from the first minute, a clot is two opposed systems running at once, one laying down a mesh to seal the wound and the other already dissolving that same mesh — and the machinery that will take the clot apart is woven into it before the bleeding even stops.
This publication keeps asking one question of very different things: what holds a shape together when nothing inside it holds still? A candle flame, a heartbeat, the steep salt gradient inside a kidney — each is a pattern that outlasts the material passing through it. A blood clot belongs to the same family, with a twist. It isn’t one process holding off decay; it’s two opposed processes fighting each other to a deliberately lopsided draw, and the body chooses exactly how lopsided, and for how long.
The building side is faster than it sounds. Older textbooks drew clotting as a “cascade” — a tidy waterfall of a dozen numbered factors, each switching on the next. Current hematology tells it as something messier and more physical: a reaction that happens in three overlapping bursts on the surfaces of cells. It begins when an injury exposes tissue factor, a protein normally walled off from the bloodstream. Tissue factor grabs a passing clotting factor and makes a first, small pulse of thrombin, the enzyme at the center of the whole story. That first pulse is almost immediately smothered by an inhibitor; on its own it seals nothing. But it is enough to summon platelets and switch on a set of cofactors, and once those assemble on the platelet surface, they convert the raw material into thrombin not in a trickle but a burst. The burst turns a dissolved blood protein, fibrinogen, into fibrin — long sticky threads — and switches on a cross-linker that welds the threads into a mesh. In a test tube, the heavy lifting is done in minutes.
Here is the part that makes a clot a standing balance rather than a one-way seal: the machinery that will take it apart is packed into it as it forms. Threaded into the fresh mesh are plasminogen, an inert protein, and tissue plasminogen activator, released from the vessel wall. Fibrin itself is the matchmaker — it makes that activator convert plasminogen into plasmin, an enzyme that chews fibrin apart, and it does this right on the clot’s own surface. So the dissolving starts in the same place, at nearly the same time, as the sealing. The scab you can see on day two is being eaten the entire time it holds.
Thrombin, meanwhile, carries its own brake. As long as it stays on the raw wound it drives clotting forward. But the instant it drifts a little way off, onto the intact wall of the vessel, it meets a protein called thrombomodulin — and binding it flips thrombin’s job inside out. The thrombin–thrombomodulin pair switches on another protein, protein C, which then destroys the very cofactors that powered the thrombin burst in the first place. The enzyme that builds the clot dismantles its own amplifiers the moment it strays past the injury. That is why a scrape seals a scrape and does not cement the whole vein shut: the clot is fenced to the wound by thrombin turning against itself at the border.
For a few days the building side is tuned to win — just barely. Then, as new tissue grows in underneath, the tilt reverses. The reinforcements slow, the plasmin keeps chewing, net buildup becomes net breakdown, and the clot is taken down roughly on the schedule the wound stops needing it. A scab does not fall off because it dried out and quit. It is actively disassembled from within, on time.
None of this is a tidy metaphor that falls apart under a clinician’s eye; the failure modes are exactly what the balance predicts. Start with too little of the building machinery and you bleed: hemophilia is the textbook case, a missing clotting factor crippling the burst, so clots form late and flimsy and joints fill with blood from injuries that should have sealed. Tip it the other way and you get the opposite disaster — a clot that forms where it shouldn’t, or refuses to dismantle, blocking a leg vein or breaking loose to lodge in a lung. And because it is a balance, medicine can lean on it on purpose. The clot-buster given for some strokes is manufactured tissue plasminogen activator, the same dissolver the vessel wall makes, pushed in — for eligible patients, within about four and a half hours — to reopen a blocked artery in the brain before the tissue behind it dies. If that dose tips too far and causes bleeding, the fix is to hand the building side its materials back. It really is a dial.
Reach up and feel any healing scrape. What is under your finger looks like the most inert thing on your body, a hard little lid doing nothing. It is the opposite: a truce, held every second by two sets of enzymes trying to undo each other’s work, tilted just far enough toward sealing to keep you from bleeding, and tilted back, on schedule, the moment you no longer need it. The bandage was digesting itself the whole time.
One loop I’m watching
Next: a shallow dish of clear liquid that turns one color, then another, then back again, on a steady beat — for close to an hour, with nobody stirring it. Not settling toward a final color and stopping, the way every chemistry class insists a reaction should, but keeping time like a clock, running on nothing but the slow spend of what’s dissolved in it.
Tip: the ← and → arrow keys move between issues.
Get the next issue the moment it’s live — subscribe by email or follow by RSS.
New to The Standing Wave? Start here →